Chirurgia (Bucur). 2021 Mar-Apr;116(2):224-231. doi: 10.21614/chirurgia.116.2.224.
Nowadays, breast cancer treatment spans from simple lesion excision to complex management including surgery (mastectomy with or without axillary lym-phadenectomy) and adjuvant treatment (chemotherapy, radiotherapy, hormonal therapy and im-munotherapy). Lately, breast reconstruction has become part of the breast cancer approach, but, while its physical and emotional benefits are undisputed, it comes with its own set of risks and complications, especially when delayed breast reconstruction after radiotherapy is performed. This paper aims to present our experience on the effects of radiotherapy in conjunction with de-layed alloplastic breast reconstruction.
We conducted a retrospective study on 16 patients with mastec-tomy for breast cancer, for whom delayed breast reconstruction was chosen. Depending on the existence of postmastectomy radiotherapy, patients were assigned to one of two groups: group 1 consisted of eight patients that received adjuvant radiotherapy and group 2 of eight patients that did not. We collected a series of data (sociodemographic, type of reconstructive intervention, adjuvant therapies, etc.) and afterwards we analyzed the cases in which complications occurred. The number and severity of complications after breast reconstruction was higher in the adjuvant radiotherapy patient group. Seven patients had complications, three of those were major: one TRAM flap partial necrosis, one expander extrusion and one chest wall cellulitis. The therapeutic approach was surgical debridement and secondary reconstruction with latissimus dorsi flap. We noted only one major complication (expander extrusion) in the no-radiotherapy group. Despite the vast array of reconstructive surgical techniques at our disposal, there is still no clear protocol regarding breast reconstruction in patients receiving radiation thera-py. The majority of patients tend to opt for the simplest intervention, i.e. expander-implant recon-struction, which is usually accompanied by complications when combined with radiotherapy. Comprehensive and open communication between oncologist, radiotherapist, plastic surgeon and patient ensures optimal results.
如今,乳腺癌的治疗方法从单纯的病变切除扩展到包括手术(乳房切除术伴或不伴腋窝淋巴结清扫术)和辅助治疗(化疗、放疗、激素治疗和免疫治疗)在内的复杂管理。最近,乳房重建已成为乳腺癌治疗方法的一部分,但尽管其具有身体和情感上的益处,但它也带来了一系列自身的风险和并发症,尤其是在进行放疗后延迟乳房重建时。本文旨在介绍我们在放疗联合延迟性假体乳房重建方面的经验。
我们对 16 例因乳腺癌行乳房切除术且选择延迟乳房重建的患者进行了回顾性研究。根据是否接受术后放疗,患者分为两组:组 1 为 8 例接受辅助放疗的患者,组 2 为 8 例未接受放疗的患者。我们收集了一系列数据(社会人口统计学、重建干预类型、辅助治疗等),然后分析了发生并发症的病例。在接受辅助放疗的患者组中,乳房重建后的并发症数量和严重程度更高。有 7 例患者出现并发症,其中 3 例为严重并发症:1 例腹壁下动脉穿支皮瓣部分坏死、1 例扩张器脱出和 1 例胸壁蜂窝织炎。治疗方法为手术清创和使用背阔肌皮瓣进行二次重建。在未接受放疗的组中,我们仅观察到 1 例严重并发症(扩张器脱出)。尽管我们有大量的重建手术技术可供选择,但对于接受放疗的患者,乳房重建仍没有明确的方案。大多数患者倾向于选择最简单的干预措施,即扩张器-植入物重建,当与放疗结合时,通常会伴有并发症。肿瘤学家、放射治疗师、整形外科医生和患者之间进行全面和开放的沟通,可确保获得最佳效果。